Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

647 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis.
Zlotta AR, Ballas LK, Niemierko A, Lajkosz K, Kuk C, Miranda G, Drumm M, Mari A, Thio E, Fleshner NE, Kulkarni GS, Jewett MAS, Bristow RG, Catton C, Berlin A, Sridhar SS, Schuckman A, Feldman AS, Wszolek M, Dahl DM, Lee RJ, Saylor PJ, Michaelson MD, Miyamoto DT, Zietman A, Shipley W, Chung P, Daneshmand S, Efstathiou JA. Zlotta AR, et al. Among authors: berlin a. Lancet Oncol. 2023 Jun;24(6):669-681. doi: 10.1016/S1470-2045(23)00170-5. Epub 2023 May 12. Lancet Oncol. 2023. PMID: 37187202
Long-term oncologic outcomes of low dose-rate brachytherapy compared to hypofractionated external beam radiotherapy for intermediate -risk prostate cancer.
Sanmamed N, Joseph L, Crook J, Craig T, Warde P, Tomasso AD, Chung P, Berlin A, Bayley A, Saibishkumar EP, Glicksman R, Raman S, Catton C, Helou J. Sanmamed N, et al. Among authors: berlin a. Brachytherapy. 2023 Mar-Apr;22(2):188-194. doi: 10.1016/j.brachy.2022.09.159. Epub 2022 Dec 20. Brachytherapy. 2023. PMID: 36549968
Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial.
Spratt DE, Liu VYT, Michalski J, Davicioni E, Berlin A, Simko JP, Efstathiou JA, Tran PT, Sandler HM, Hall WA, Thompson DJS, Parliament MB, Dayes IS, Correa RJM, Robertson JM, Gore EM, Doncals DE, Vigneault E, Souhami L, Karrison TG, Feng FY. Spratt DE, et al. Among authors: berlin a. Int J Radiat Oncol Biol Phys. 2023 Oct 1;117(2):370-377. doi: 10.1016/j.ijrobp.2023.04.010. Epub 2023 May 2. Int J Radiat Oncol Biol Phys. 2023. PMID: 37137444 Free PMC article. Clinical Trial.
Practice-based training strategy for therapist-driven prostate MR-Linac adaptive radiotherapy.
Li W, Padayachee J, Navarro I, Winter J, Dang J, Raman S, Kong V, Berlin A, Catton C, Glicksman R, Malkov V, McPartlin A, Kataki K, Lindsay P, Chung P. Li W, et al. Among authors: berlin a. Tech Innov Patient Support Radiat Oncol. 2023 May 13;27:100212. doi: 10.1016/j.tipsro.2023.100212. eCollection 2023 Sep. Tech Innov Patient Support Radiat Oncol. 2023. PMID: 37265510 Free PMC article.
Lymphotropic Pattern of Prostate-specific Membrane Antigen-detected Metastases Among Biochemically Recurrent Radical Prostatectomy Patients with Cribriform Disease.
Bernardino R, Sayyid RK, Al-Daqqaq Z, Tiwari R, Cockburn J, Vijayakanthan S, Qaoud Y, Berjaoui MB, Metser U, Berlin A, van der Kwast T, Fleshner NE. Bernardino R, et al. Among authors: berlin a. Eur Urol Focus. 2023 Nov;9(6):1016-1023. doi: 10.1016/j.euf.2023.05.005. Epub 2023 May 31. Eur Urol Focus. 2023. PMID: 37268513
Poly(adenosine diphosphate-ribose) polymerase inhibitor combinations in first-line metastatic castrate-resistant prostate cancer setting: a systematic review and meta-analysis.
Sayyid RK, Klaassen Z, Berlin A, Roy S, Brandão LR, Bernardino R, Chavarriaga J, Jiang DM, Spratt DE, Fleshner NE, Wallis CJD. Sayyid RK, et al. Among authors: berlin a. BJU Int. 2023 Dec;132(6):619-630. doi: 10.1111/bju.16130. Epub 2023 Jul 28. BJU Int. 2023. PMID: 37461140 Review.
Primary Bladder Sarcoma: A multi-institutional experience from the Rare Cancer Network.
Bettoli P, Liu Z, Jara N, Bakal F, Wong W, Terlizzi M, Sargos P, Zilli T, Thariat J, Sole S, Ploussard G, Goyal S, Chung P, Berlin A, Sole C. Bettoli P, et al. Among authors: berlin a. Arch Ital Urol Androl. 2023 Jul 25;95(3):11533. doi: 10.4081/aiua.2023.11533. Arch Ital Urol Androl. 2023. PMID: 37491942 Free article.
647 results